Core Insights - XtalPi Inc. has successfully deployed an automated formulation stability testing workstation at BASF, enhancing BASF's R&D capabilities in the chemical industry [1][2][3] - This collaboration marks a significant milestone for XtalPi, showcasing its technological leadership and ability to provide scalable solutions for industry leaders [1][5] Company Overview - XtalPi is a global leader in AI- and robotics-driven R&D platforms, focusing on innovation in pharmaceuticals, petrochemicals, new energy, and advanced materials [1][9] - Founded in 2015 by MIT physicists, XtalPi integrates quantum physics, AI, and robotics to deliver digital and intelligent R&D solutions across various industries [9] Collaboration with BASF - BASF, a major player in the chemical industry, operates in diverse sectors and is committed to green transformation [2][10] - The automated workstation developed by XtalPi addresses BASF's challenges in traditional manual workflows, enhancing efficiency, accuracy, and standardization in testing processes [3][4] Technological Advancements - XtalPi's automated system integrates sample management, analytical testing, and data management into a cohesive workflow, significantly improving operational efficiency [1][3] - The modular and standardized platform allows for rapid deployment and customization, meeting the unique requirements of BASF [4][5] Market Position and Future Outlook - XtalPi's solutions are deployed across various industries, including pharmaceuticals and renewable energy, positioning the company for growth in trillion-dollar markets [7] - The company aims to deepen strategic partnerships with global industry leaders to drive advancements in AI and robotic experimentation [8]

INSILICO MEDICINE InSilico Medicine Cayman TopCo 英矽智能 (Incorporated in the Cayman Islands with limited liability) WARNING The publication of this announcement is required by The Stock Exchange of Hong Kong Limited (the "Stock Exchange") and the Securities and Futures Commission (the "Commission") solely for the purpose of providing information to the public in Hong Kong. By viewing this announcement, you acknowledge, accept and agree with InSilico Medicine Cayman TopCo (英矽智能) (the "Company"), its joint spon ...